Literature DB >> 10872195

Alport syndromes: phenotypic heterogeneity of progressive hereditary nephritis.

C E Kashtan1.   

Abstract

Alport syndrome is a primary genetic disease of basement membranes, manifested clinically as a progressive nephropathy variably associated with sensorineural deafness and a plethora of ocular abnormalities. The long-recognized phenotypic heterogeneity of Alport syndrome may be considered on several levels, including basement membrane biochemistry, basement membrane ultrastructure, the natural history of the nephropathy, and the occurrence of extrarenal abnormalities. This review discusses the possible molecular bases for the heterogeneity. The discussion draws upon recent insights into the molecular genetics of Alport syndrome, and the biochemistry of normal and Alport syndrome basement membranes, in order to provide a framework for understanding the variable renal and extrarenal manifestations of the disease.

Entities:  

Mesh:

Year:  2000        PMID: 10872195     DOI: 10.1007/s004670050804

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  8 in total

1.  Genotype-phenotype correlation in X-linked Alport syndrome.

Authors:  Mir Reza Bekheirnia; Berenice Reed; Martin C Gregory; Kim McFann; Alireza Abdollah Shamshirsaz; Amirali Masoumi; Robert W Schrier
Journal:  J Am Soc Nephrol       Date:  2010-04-08       Impact factor: 10.121

Review 2.  Organogenesis of the kidney glomerulus: focus on the glomerular basement membrane.

Authors:  Jeffrey H Miner
Journal:  Organogenesis       Date:  2011-04-01       Impact factor: 2.500

3.  The effect of aldosterone blockade in patients with Alport syndrome.

Authors:  Hiroshi Kaito; Kandai Nozu; Kazumoto Iijima; Koichi Nakanishi; Kunihiko Yoshiya; Kyoko Kanda; Rafal Przybyslaw Krol; Norishige Yoshikawa; Masafumi Matsuo
Journal:  Pediatr Nephrol       Date:  2006-10-13       Impact factor: 3.714

Review 4.  Glomerular basement membrane composition and the filtration barrier.

Authors:  Jeffrey H Miner
Journal:  Pediatr Nephrol       Date:  2011-02-15       Impact factor: 3.714

5.  Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome.

Authors:  Jian-Hong Liu; Xiu-Xiu Wei; Ang Li; Ying-Xia Cui; Xin-Yi Xia; Wei-Song Qin; Ming-Chao Zhang; Er-Zhi Gao; Jun Sun; Chun-Lin Gao; Feng-Xia Liu; Qiu-Yue Wu; Wei-Wei Li; Zhi-Hong Liu; Xiao-Jun Li
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

6.  Identification of four novel mutations in the COL4A5 gene identified in Chinese patients with X-linked Alport syndrome.

Authors:  Xuechao Zhao; Xueliang Shang; Chen Chen; Lina Liu; Conghui Wang; Ganye Zhao; Junjun Zhang; Xiangdong Kong
Journal:  Biomed Rep       Date:  2020-06-09

7.  An organ-derived extracellular matrix triggers in situ kidney regeneration in a preclinical model.

Authors:  Kazuki Tajima; Hiroshi Yagi; Toshinori Morisaku; Kotaro Nishi; Hiroko Kushige; Hideaki Kojima; Hisanobu Higashi; Kohei Kuroda; Minoru Kitago; Shungo Adachi; Tohru Natsume; Kumiko Nishimura; Mototsugu Oya; Yuko Kitagawa
Journal:  NPJ Regen Med       Date:  2022-02-28

8.  Efficient Targeted Next Generation Sequencing-Based Workflow for Differential Diagnosis of Alport-Related Disorders.

Authors:  Gábor Kovács; Tibor Kalmár; Emőke Endreffy; Zoltán Ondrik; Béla Iványi; Csaba Rikker; Ibolya Haszon; Sándor Túri; Mária Sinkó; Csaba Bereczki; Zoltán Maróti
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.